RE: It’s in Auction1 Dec 2025 09:48
Leew this is the game changer and could be worth the money,
"Company acquiring the exclusive licence rights to AO-252, a novel first-in-class, first-in-human new drug alternative targeting the TACC3 protein for the treatment of certain cancers, initially announced by the Company on 8 September 2025"